Comparison of fluorescent spot test and G-6-PD activity assay versus G-6-PD mutation analysis for detection of G-6-PD deficiency in newborns
Main Article Content
Abstract
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, due to mutations in the X-linkedG-6-PD gene, is the most common enzyme defect in the world. Fluorescent spot test (FST) and G-6-PD activity assay are widely used for diagnosis of G-6-PD deficiency. The aim of this study was to compare the effectiveness of FST and G-6-PD activity assay for detection of G-6-PD deficiency with G-6-PD mutation analysis. EDTA-blood samples of 270 neonates (130 males and 140 females) were recruited from three hospital laboratories in northeast Thailand after performing the FST. All samples were further investigated for G-6-PD activity and G-6-PD mutation. In male neonates, FST showed 98.1% sensitivity and 94.8% specificity, and G-6-PD activity assay had 100% sensitivity and 90.9% specificity). Among females, both FST and G-6-PD activity assay showed low sensitivity as 42.9% and retained high specificity of 100% and 96.2%, respectively. This study demonstrated a comparable effectiveness of FST and G-6-PD activity assay for diagnosis of G-6-PD deficiency. However, these 2 methods exhibited low sensitivity to identify females who carry G-6-PD gene mutation. The definitive diagnosis of these females requires molecular detection of G-6-PD mutation.This data is useful for each hospital to select a G-6-PD test which is fit for the propose of investigation, budget and number of samples.
Article Details
This is an open-access article, permitting unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The views and opinions expressed by the contributors in their articles are solely their own and do not necessarily reflect the official policy or position of Arch AHS.